This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. shed 9.8% to $2.02 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.1% to 43,461.21 and the NASDAQ Composite Index falling 1.2% to 19,286.92.
Inovio Pharmaceuticals Inc. closed 86.3% below its 52-week high of $14.75, which the company achieved on April 1st.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 0.9% to $163.74, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 1.33% to $26.65.
Trading volume totaled 835,891, compared to the 50-day average of 1.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 24, 2025 16:33 ET (21:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.